Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus

Todd M. Doran, Jumpei Morimoto, Scott Simanski, Eric J. Koesema, Lorraine F. Clark, Kevin Pels, Sydney L. Stoops, Alberto Pugliese, Jay S Skyler, Thomas Kodadek

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Summary A major goal in understanding autoimmune diseases is to define the antigens that elicit a self-destructive immune response, but this is a difficult endeavor. In an effort to discover autoantigens associated with type 1 diabetes (T1D), we used epitope surrogate technology that screens combinatorial libraries of synthetic molecules for compounds that could recognize disease-linked autoantibodies and enrich them from serum. Autoantibodies from one patient revealed a highly phosphorylated form of peripherin, a neuroendocrine filament protein, as a candidate T1D antigen. Peripherin antibodies were detected in 72% of donor patient sera. Further analysis revealed that the T1D-associated antibodies only recognized a dimeric conformation of peripherin. These data explain why peripherin was dismissed as an important T1D antigen previously. The discovery of this novel autoantigen would not have been possible using standard methods, such as hybridizing serum antibodies to recombinant protein arrays, highlighting the power of epitope surrogate technology for probing the mechanism of autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)618-628
Number of pages11
JournalCell Chemical Biology
Volume23
Issue number5
DOIs
StatePublished - May 19 2016

Fingerprint

Peripherins
Autoantigens
Medical problems
Type 1 Diabetes Mellitus
Antigens
Autoantibodies
Autoimmune Diseases
Antibodies
Epitopes
Serum
Technology
Protein Array Analysis
Recombinant Proteins
Conformations
Tissue Donors
Molecules
Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Molecular Medicine
  • Drug Discovery
  • Pharmacology

Cite this

Doran, T. M., Morimoto, J., Simanski, S., Koesema, E. J., Clark, L. F., Pels, K., ... Kodadek, T. (2016). Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus. Cell Chemical Biology, 23(5), 618-628. https://doi.org/10.1016/j.chembiol.2016.04.006

Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus. / Doran, Todd M.; Morimoto, Jumpei; Simanski, Scott; Koesema, Eric J.; Clark, Lorraine F.; Pels, Kevin; Stoops, Sydney L.; Pugliese, Alberto; Skyler, Jay S; Kodadek, Thomas.

In: Cell Chemical Biology, Vol. 23, No. 5, 19.05.2016, p. 618-628.

Research output: Contribution to journalArticle

Doran, TM, Morimoto, J, Simanski, S, Koesema, EJ, Clark, LF, Pels, K, Stoops, SL, Pugliese, A, Skyler, JS & Kodadek, T 2016, 'Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus', Cell Chemical Biology, vol. 23, no. 5, pp. 618-628. https://doi.org/10.1016/j.chembiol.2016.04.006
Doran, Todd M. ; Morimoto, Jumpei ; Simanski, Scott ; Koesema, Eric J. ; Clark, Lorraine F. ; Pels, Kevin ; Stoops, Sydney L. ; Pugliese, Alberto ; Skyler, Jay S ; Kodadek, Thomas. / Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus. In: Cell Chemical Biology. 2016 ; Vol. 23, No. 5. pp. 618-628.
@article{cf082507d7e044b3b3b34ae4411edcd8,
title = "Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus",
abstract = "Summary A major goal in understanding autoimmune diseases is to define the antigens that elicit a self-destructive immune response, but this is a difficult endeavor. In an effort to discover autoantigens associated with type 1 diabetes (T1D), we used epitope surrogate technology that screens combinatorial libraries of synthetic molecules for compounds that could recognize disease-linked autoantibodies and enrich them from serum. Autoantibodies from one patient revealed a highly phosphorylated form of peripherin, a neuroendocrine filament protein, as a candidate T1D antigen. Peripherin antibodies were detected in 72{\%} of donor patient sera. Further analysis revealed that the T1D-associated antibodies only recognized a dimeric conformation of peripherin. These data explain why peripherin was dismissed as an important T1D antigen previously. The discovery of this novel autoantigen would not have been possible using standard methods, such as hybridizing serum antibodies to recombinant protein arrays, highlighting the power of epitope surrogate technology for probing the mechanism of autoimmune diseases.",
author = "Doran, {Todd M.} and Jumpei Morimoto and Scott Simanski and Koesema, {Eric J.} and Clark, {Lorraine F.} and Kevin Pels and Stoops, {Sydney L.} and Alberto Pugliese and Skyler, {Jay S} and Thomas Kodadek",
year = "2016",
month = "5",
day = "19",
doi = "10.1016/j.chembiol.2016.04.006",
language = "English (US)",
volume = "23",
pages = "618--628",
journal = "Cell Chemical Biology",
issn = "2451-9448",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Discovery of Phosphorylated Peripherin as a Major Humoral Autoantigen in Type 1 Diabetes Mellitus

AU - Doran, Todd M.

AU - Morimoto, Jumpei

AU - Simanski, Scott

AU - Koesema, Eric J.

AU - Clark, Lorraine F.

AU - Pels, Kevin

AU - Stoops, Sydney L.

AU - Pugliese, Alberto

AU - Skyler, Jay S

AU - Kodadek, Thomas

PY - 2016/5/19

Y1 - 2016/5/19

N2 - Summary A major goal in understanding autoimmune diseases is to define the antigens that elicit a self-destructive immune response, but this is a difficult endeavor. In an effort to discover autoantigens associated with type 1 diabetes (T1D), we used epitope surrogate technology that screens combinatorial libraries of synthetic molecules for compounds that could recognize disease-linked autoantibodies and enrich them from serum. Autoantibodies from one patient revealed a highly phosphorylated form of peripherin, a neuroendocrine filament protein, as a candidate T1D antigen. Peripherin antibodies were detected in 72% of donor patient sera. Further analysis revealed that the T1D-associated antibodies only recognized a dimeric conformation of peripherin. These data explain why peripherin was dismissed as an important T1D antigen previously. The discovery of this novel autoantigen would not have been possible using standard methods, such as hybridizing serum antibodies to recombinant protein arrays, highlighting the power of epitope surrogate technology for probing the mechanism of autoimmune diseases.

AB - Summary A major goal in understanding autoimmune diseases is to define the antigens that elicit a self-destructive immune response, but this is a difficult endeavor. In an effort to discover autoantigens associated with type 1 diabetes (T1D), we used epitope surrogate technology that screens combinatorial libraries of synthetic molecules for compounds that could recognize disease-linked autoantibodies and enrich them from serum. Autoantibodies from one patient revealed a highly phosphorylated form of peripherin, a neuroendocrine filament protein, as a candidate T1D antigen. Peripherin antibodies were detected in 72% of donor patient sera. Further analysis revealed that the T1D-associated antibodies only recognized a dimeric conformation of peripherin. These data explain why peripherin was dismissed as an important T1D antigen previously. The discovery of this novel autoantigen would not have been possible using standard methods, such as hybridizing serum antibodies to recombinant protein arrays, highlighting the power of epitope surrogate technology for probing the mechanism of autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=84975045624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975045624&partnerID=8YFLogxK

U2 - 10.1016/j.chembiol.2016.04.006

DO - 10.1016/j.chembiol.2016.04.006

M3 - Article

C2 - 27185639

AN - SCOPUS:84975045624

VL - 23

SP - 618

EP - 628

JO - Cell Chemical Biology

JF - Cell Chemical Biology

SN - 2451-9448

IS - 5

ER -